A, R., P, B., D, B., M, D., Y, F., I, G., . . . P, B. (2023). A comprehensive regulatory and industry review of modeling and simulation practices in oncology clinical drug development. Journal of pharmacokinetics and pharmacodynamics, 50(3), 147. https://doi.org/10.1007/s10928-023-09850-2
Chicago Style (17th ed.) CitationA, Ruiz-Garcia, et al. "A Comprehensive Regulatory and Industry Review of Modeling and Simulation Practices in Oncology Clinical Drug Development." Journal of Pharmacokinetics and Pharmacodynamics 50, no. 3 (2023): 147. https://doi.org/10.1007/s10928-023-09850-2.
MLA (9th ed.) CitationA, Ruiz-Garcia, et al. "A Comprehensive Regulatory and Industry Review of Modeling and Simulation Practices in Oncology Clinical Drug Development." Journal of Pharmacokinetics and Pharmacodynamics, vol. 50, no. 3, 2023, p. 147, https://doi.org/10.1007/s10928-023-09850-2.